
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BNTX] BioNTech SE ADS - Shareholder Equity / Assets
Data updated 2023-Sep-16 (Saturday)Note: Detailed Statistics for Shareholder Equity / Assets in Balance Sheet for BioNTech SE ADS [NASDAQ:BNTX] with frequency distribution chart that analyze trends & history . Total Shareholder Equity / Total Assets is expressed as a %. View Balance Sheet for broader context
Share
Quarterly Shareholder Equity / Assets values for BioNTech SE ADS are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | 89.6% | 91.8% | 86.2% | 81.1% | 79.6% | 78.4% |
Sequential Quarter Growth | -2.4% | +6.5% | +6.3% | +1.9% | +1.5% | +4.3% |
Quarter-on Quarter Growth | +12.6% | +17.1% | +14.7% | +32.4% | +32.8% | +30.8% |
Annual Shareholder Equity / Assets values for BioNTech SE ADS are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | 2017-Dec | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | 86.2% | 75.1% | 59.2% | 61.9% | 40.8% | -13.1% |
Year-on-Year Growth | +14.7% | +27.0% | -4.4% | +51.9% | +410.8% | -267.9% |
2-yr CAGR | +20.7% | +10.2% | +20.5% | +128.4% | ||
3-yr CAGR | +11.6% | +22.6% | +99.4% | |||
4-yr CAGR | +20.6% | +65.9% | ||||
5-yr CAGR | +57.3% |
Frequency distribution of quarterly Shareholder Equity / Assets values from 2018-Dec-31 grouped into buckets. Latest Shareholder Equity / Assets value is 89.6 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for BioNTech SE ADS mapped with quarterly Shareholder Equity / Assets values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Shareholder Equity / Assets above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for BioNTech SE ADS with subsequent post-earnings performance given Shareholder Equity / Assets values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Shareholder Equity / Assets - Low | 40% | 60% |
Shareholder Equity / Assets - Medium | 40% | 60% |
Shareholder Equity / Assets - High | 75% | 25% |
Shareholder Equity / Assets (Sequential growth %) - Low | 20% | 80% |
Shareholder Equity / Assets (Sequential growth %) - Medium | 80% | 20% |
Shareholder Equity / Assets (Sequential growth %) - High | 50% | 50% |
Shareholder Equity / Assets (QoQ growth %) - Low | 50% | 50% |
Shareholder Equity / Assets (QoQ growth %) - Medium | 50% | 50% |
Shareholder Equity / Assets (QoQ growth %) - High | 75% | 25% |
Related to BioNTech SE ADS
Information for BioNTech SE ADS
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jun-12 on Google
SEC Reports : Quarterly reports around 2025-Jun-12 on SEC Edgar
Compare BioNTech SE ADS with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes BioNTech SE ADS
Industry : Biotechnology industry performance which includes BioNTech SE ADS